China Peptides Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Peptides market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Peptides market. Detailed analysis of key players, along with key growth strategies adopted by Peptides industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • VHB Life Sciences Limited

    • Gland Pharma Limited

    • Samarth Life Sciences Pvt Ltd

    • Celon Laboratories Pvt Ltd

    • United Biotech (P) Limited

    • Biological E Limited

    • Troikaa Pharmaceuticals Ltd

    • Emcure Pharmaceuticals Pvt Ltd

    • Cipla Ltd

    • Bharat Biotech

    By Type:

    • Insulin

    • Teriparatide

    • Liraglutide

    • Leuprolide

    By End-User:

    • Diabetes

    • Infectious Diseases

    • Cancer

    • Osteoporosis

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptides Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Peptides Market Size and Growth Rate of Insulin from 2016 to 2027

    • 1.3.2 China Peptides Market Size and Growth Rate of Teriparatide from 2016 to 2027

    • 1.3.3 China Peptides Market Size and Growth Rate of Liraglutide from 2016 to 2027

    • 1.3.4 China Peptides Market Size and Growth Rate of Leuprolide from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Peptides Market Size and Growth Rate of Diabetes from 2016 to 2027

    • 1.4.2 China Peptides Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • 1.4.3 China Peptides Market Size and Growth Rate of Cancer from 2016 to 2027

    • 1.4.4 China Peptides Market Size and Growth Rate of Osteoporosis from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Peptides Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Peptides by Major Types

    • 3.4.1 Market Size and Growth Rate of Insulin

    • 3.4.2 Market Size and Growth Rate of Teriparatide

    • 3.4.3 Market Size and Growth Rate of Liraglutide

    • 3.4.4 Market Size and Growth Rate of Leuprolide

    4 Segmentation of Peptides Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Peptides by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Peptides in Diabetes

    • 4.4.2 Market Size and Growth Rate of Peptides in Infectious Diseases

    • 4.4.3 Market Size and Growth Rate of Peptides in Cancer

    • 4.4.4 Market Size and Growth Rate of Peptides in Osteoporosis

    5 Market Analysis by Regions

    • 5.1 China Peptides Production Analysis by Regions

    • 5.2 China Peptides Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Peptides Landscape Analysis

    • 6.1 North China Peptides Landscape Analysis by Major Types

    • 6.2 North China Peptides Landscape Analysis by Major End-Users

    7 Central China Peptides Landscape Analysis

    • 7.1 Central China Peptides Landscape Analysis by Major Types

    • 7.2 Central China Peptides Landscape Analysis by Major End-Users

    8 South China Peptides Landscape Analysis

    • 8.1 South China Peptides Landscape Analysis by Major Types

    • 8.2 South China Peptides Landscape Analysis by Major End-Users

    9 East China Peptides Landscape Analysis

    • 9.1 East China Peptides Landscape Analysis by Major Types

    • 9.2 East China Peptides Landscape Analysis by Major End-Users

    10 Northeast China Peptides Landscape Analysis

    • 10.1 Northeast China Peptides Landscape Analysis by Major Types

    • 10.2 Northeast China Peptides Landscape Analysis by Major End-Users

    11 Southwest China Peptides Landscape Analysis

    • 11.1 Southwest China Peptides Landscape Analysis by Major Types

    • 11.2 Southwest China Peptides Landscape Analysis by Major End-Users

    12 Northwest China Peptides Landscape Analysis

    • 12.1 Northwest China Peptides Landscape Analysis by Major Types

    • 12.2 Northwest China Peptides Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 VHB Life Sciences Limited

      • 13.1.1 VHB Life Sciences Limited Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Gland Pharma Limited

      • 13.2.1 Gland Pharma Limited Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Samarth Life Sciences Pvt Ltd

      • 13.3.1 Samarth Life Sciences Pvt Ltd Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Celon Laboratories Pvt Ltd

      • 13.4.1 Celon Laboratories Pvt Ltd Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 United Biotech (P) Limited

      • 13.5.1 United Biotech (P) Limited Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Biological E Limited

      • 13.6.1 Biological E Limited Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Troikaa Pharmaceuticals Ltd

      • 13.7.1 Troikaa Pharmaceuticals Ltd Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Emcure Pharmaceuticals Pvt Ltd

      • 13.8.1 Emcure Pharmaceuticals Pvt Ltd Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Cipla Ltd

      • 13.9.1 Cipla Ltd Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Bharat Biotech

      • 13.10.1 Bharat Biotech Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Peptides Market Size and Growth Rate of Insulin from 2016 to 2027

    • Figure China Peptides Market Size and Growth Rate of Teriparatide from 2016 to 2027

    • Figure China Peptides Market Size and Growth Rate of Liraglutide from 2016 to 2027

    • Figure China Peptides Market Size and Growth Rate of Leuprolide from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Peptides Market Size and Growth Rate of Diabetes from 2016 to 2027

    • Figure China Peptides Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • Figure China Peptides Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure China Peptides Market Size and Growth Rate of Osteoporosis from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Peptides Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Peptides Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Peptides

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Peptides by Different Types from 2016 to 2027

    • Table Consumption Share of Peptides by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Insulin

    • Figure Market Size and Growth Rate of Teriparatide

    • Figure Market Size and Growth Rate of Liraglutide

    • Figure Market Size and Growth Rate of Leuprolide

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Peptides by Different End-Users from 2016 to 2027

    • Table Consumption Share of Peptides by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Osteoporosis

    • Table China Peptides Production by Regions

    • Table China Peptides Production Share by Regions

    • Figure China Peptides Production Share by Regions in 2016

    • Figure China Peptides Production Share by Regions in 2021

    • Figure China Peptides Production Share by Regions in 2027

    • Table China Peptides Consumption by Regions

    • Table China Peptides Consumption Share by Regions

    • Figure China Peptides Consumption Share by Regions in 2016

    • Figure China Peptides Consumption Share by Regions in 2021

    • Figure China Peptides Consumption Share by Regions in 2027

    • Table North China Peptides Consumption by Types from 2016 to 2027

    • Table North China Peptides Consumption Share by Types from 2016 to 2027

    • Figure North China Peptides Consumption Share by Types in 2016

    • Figure North China Peptides Consumption Share by Types in 2021

    • Figure North China Peptides Consumption Share by Types in 2027

    • Table North China Peptides Consumption by End-Users from 2016 to 2027

    • Table North China Peptides Consumption Share by End-Users from 2016 to 2027

    • Figure North China Peptides Consumption Share by End-Users in 2016

    • Figure North China Peptides Consumption Share by End-Users in 2021

    • Figure North China Peptides Consumption Share by End-Users in 2027

    • Table Central China Peptides Consumption by Types from 2016 to 2027

    • Table Central China Peptides Consumption Share by Types from 2016 to 2027

    • Figure Central China Peptides Consumption Share by Types in 2016

    • Figure Central China Peptides Consumption Share by Types in 2021

    • Figure Central China Peptides Consumption Share by Types in 2027

    • Table Central China Peptides Consumption by End-Users from 2016 to 2027

    • Table Central China Peptides Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Peptides Consumption Share by End-Users in 2016

    • Figure Central China Peptides Consumption Share by End-Users in 2021

    • Figure Central China Peptides Consumption Share by End-Users in 2027

    • Table South China Peptides Consumption by Types from 2016 to 2027

    • Table South China Peptides Consumption Share by Types from 2016 to 2027

    • Figure South China Peptides Consumption Share by Types in 2016

    • Figure South China Peptides Consumption Share by Types in 2021

    • Figure South China Peptides Consumption Share by Types in 2027

    • Table South China Peptides Consumption by End-Users from 2016 to 2027

    • Table South China Peptides Consumption Share by End-Users from 2016 to 2027

    • Figure South China Peptides Consumption Share by End-Users in 2016

    • Figure South China Peptides Consumption Share by End-Users in 2021

    • Figure South China Peptides Consumption Share by End-Users in 2027

    • Table East China Peptides Consumption by Types from 2016 to 2027

    • Table East China Peptides Consumption Share by Types from 2016 to 2027

    • Figure East China Peptides Consumption Share by Types in 2016

    • Figure East China Peptides Consumption Share by Types in 2021

    • Figure East China Peptides Consumption Share by Types in 2027

    • Table East China Peptides Consumption by End-Users from 2016 to 2027

    • Table East China Peptides Consumption Share by End-Users from 2016 to 2027

    • Figure East China Peptides Consumption Share by End-Users in 2016

    • Figure East China Peptides Consumption Share by End-Users in 2021

    • Figure East China Peptides Consumption Share by End-Users in 2027

    • Table Northeast China Peptides Consumption by Types from 2016 to 2027

    • Table Northeast China Peptides Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Peptides Consumption Share by Types in 2016

    • Figure Northeast China Peptides Consumption Share by Types in 2021

    • Figure Northeast China Peptides Consumption Share by Types in 2027

    • Table Northeast China Peptides Consumption by End-Users from 2016 to 2027

    • Table Northeast China Peptides Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Peptides Consumption Share by End-Users in 2016

    • Figure Northeast China Peptides Consumption Share by End-Users in 2021

    • Figure Northeast China Peptides Consumption Share by End-Users in 2027

    • Table Southwest China Peptides Consumption by Types from 2016 to 2027

    • Table Southwest China Peptides Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Peptides Consumption Share by Types in 2016

    • Figure Southwest China Peptides Consumption Share by Types in 2021

    • Figure Southwest China Peptides Consumption Share by Types in 2027

    • Table Southwest China Peptides Consumption by End-Users from 2016 to 2027

    • Table Southwest China Peptides Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Peptides Consumption Share by End-Users in 2016

    • Figure Southwest China Peptides Consumption Share by End-Users in 2021

    • Figure Southwest China Peptides Consumption Share by End-Users in 2027

    • Table Northwest China Peptides Consumption by Types from 2016 to 2027

    • Table Northwest China Peptides Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Peptides Consumption Share by Types in 2016

    • Figure Northwest China Peptides Consumption Share by Types in 2021

    • Figure Northwest China Peptides Consumption Share by Types in 2027

    • Table Northwest China Peptides Consumption by End-Users from 2016 to 2027

    • Table Northwest China Peptides Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Peptides Consumption Share by End-Users in 2016

    • Figure Northwest China Peptides Consumption Share by End-Users in 2021

    • Figure Northwest China Peptides Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of VHB Life Sciences Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of VHB Life Sciences Limited

    • Figure Sales and Growth Rate Analysis of VHB Life Sciences Limited

    • Figure Revenue and Market Share Analysis of VHB Life Sciences Limited

    • Table Product and Service Introduction of VHB Life Sciences Limited

    • Table Company Profile and Development Status of Gland Pharma Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gland Pharma Limited

    • Figure Sales and Growth Rate Analysis of Gland Pharma Limited

    • Figure Revenue and Market Share Analysis of Gland Pharma Limited

    • Table Product and Service Introduction of Gland Pharma Limited

    • Table Company Profile and Development Status of Samarth Life Sciences Pvt Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samarth Life Sciences Pvt Ltd

    • Figure Sales and Growth Rate Analysis of Samarth Life Sciences Pvt Ltd

    • Figure Revenue and Market Share Analysis of Samarth Life Sciences Pvt Ltd

    • Table Product and Service Introduction of Samarth Life Sciences Pvt Ltd

    • Table Company Profile and Development Status of Celon Laboratories Pvt Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celon Laboratories Pvt Ltd

    • Figure Sales and Growth Rate Analysis of Celon Laboratories Pvt Ltd

    • Figure Revenue and Market Share Analysis of Celon Laboratories Pvt Ltd

    • Table Product and Service Introduction of Celon Laboratories Pvt Ltd

    • Table Company Profile and Development Status of United Biotech (P) Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of United Biotech (P) Limited

    • Figure Sales and Growth Rate Analysis of United Biotech (P) Limited

    • Figure Revenue and Market Share Analysis of United Biotech (P) Limited

    • Table Product and Service Introduction of United Biotech (P) Limited

    • Table Company Profile and Development Status of Biological E Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biological E Limited

    • Figure Sales and Growth Rate Analysis of Biological E Limited

    • Figure Revenue and Market Share Analysis of Biological E Limited

    • Table Product and Service Introduction of Biological E Limited

    • Table Company Profile and Development Status of Troikaa Pharmaceuticals Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Troikaa Pharmaceuticals Ltd

    • Figure Sales and Growth Rate Analysis of Troikaa Pharmaceuticals Ltd

    • Figure Revenue and Market Share Analysis of Troikaa Pharmaceuticals Ltd

    • Table Product and Service Introduction of Troikaa Pharmaceuticals Ltd

    • Table Company Profile and Development Status of Emcure Pharmaceuticals Pvt Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emcure Pharmaceuticals Pvt Ltd

    • Figure Sales and Growth Rate Analysis of Emcure Pharmaceuticals Pvt Ltd

    • Figure Revenue and Market Share Analysis of Emcure Pharmaceuticals Pvt Ltd

    • Table Product and Service Introduction of Emcure Pharmaceuticals Pvt Ltd

    • Table Company Profile and Development Status of Cipla Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla Ltd

    • Figure Sales and Growth Rate Analysis of Cipla Ltd

    • Figure Revenue and Market Share Analysis of Cipla Ltd

    • Table Product and Service Introduction of Cipla Ltd

    • Table Company Profile and Development Status of Bharat Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech

    • Figure Sales and Growth Rate Analysis of Bharat Biotech

    • Figure Revenue and Market Share Analysis of Bharat Biotech

    • Table Product and Service Introduction of Bharat Biotech


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.